{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T08:34:45Z","timestamp":1789893285260,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007077","name":"National Institute of Biomedical Innovation","doi-asserted-by":"publisher","award":["06\u201342"],"award-info":[{"award-number":["06\u201342"]}],"id":[{"id":"10.13039\/501100007077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.clim.2011.10.002","type":"journal-article","created":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T02:11:24Z","timestamp":1318903884000},"page":"167-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model"],"prefix":"10.1016","volume":"142","author":[{"given":"Hideyuki","family":"Ujiie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Shibaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Nishie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Shinkuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reine","family":"Moriuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjiang","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2011.10.002_bb0190","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1172\/JCI114812","article-title":"Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome","volume":"86","author":"Diaz","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2011.10.002_bb0010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/1523-1747.ep12616580","article-title":"Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180","volume":"99","author":"Giudice","year":"1992","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2011.10.002_bb0015","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/1523-1747.ep12616615","article-title":"Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: molecular and cell biologic characterization","volume":"99","author":"Hopkinson","year":"1992","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2011.10.002_bb0020","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1172\/JCI116368","volume":"91","author":"Ishiko","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2011.10.002_bb0025","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/1523-1747.ep12292701","article-title":"Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida","volume":"108","author":"Bedane","year":"1997","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2011.10.002_bb0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0923-1811(03)00045-8","article-title":"Epidermal basement membrane zone components: ultrastructural distribution and molecular interactions","volume":"31","author":"McMillan","year":"2003","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.clim.2011.10.002_bb0035","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.4049\/jimmunol.151.10.5742","article-title":"Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain","volume":"151","author":"Giudice","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2011.10.002_bb0040","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/1523-1747.ep12337492","article-title":"Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies","volume":"109","author":"Zillikens","year":"1997","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2011.10.002_bb0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jdermsci.2004.10.007","article-title":"Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid","volume":"37","author":"Tsuji-Abe","year":"2005","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.clim.2011.10.002_bb0050","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.4049\/jimmunol.0903101","article-title":"A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen","volume":"184","author":"Ujiie","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2011.10.002_bb0055","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1172\/JCI3335","article-title":"Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls","volume":"102","author":"Budinger","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2011.10.002_bb0060","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1046\/j.1523-1747.2000.00153.x","article-title":"Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain","volume":"115","author":"Lin","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2011.10.002_bb0065","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.4049\/jimmunol.176.3.2015","article-title":"Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230","volume":"176","author":"Thoma-Uszynski","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2011.10.002_bb0070","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1073\/pnas.93.16.8569","article-title":"A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid","volume":"93","author":"Delgado","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.clim.2011.10.002_bb0075","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2133.2004.06056.x","article-title":"A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice","volume":"151","author":"Aoki-Ota","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2011.10.002_bb0080","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.4049\/jimmunol.0901412","article-title":"T cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita","volume":"184","author":"Sitaru","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2011.10.002_bb0085","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1084\/jem.184.2.349","article-title":"Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis","volume":"184","author":"Zhang","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2011.10.002_bb0090","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1073\/pnas.89.14.6550","article-title":"A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells","volume":"89","author":"Noelle","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.clim.2011.10.002_bb0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.smim.2009.05.012","article-title":"CD40 and autoimmunity: the dark side of a great activator","volume":"21","author":"Peters","year":"2009","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.clim.2011.10.002_bb0100","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.4049\/jimmunol.166.11.6893","article-title":"Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4","volume":"166","author":"Im","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2011.10.002_bb0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.jid.5700016","article-title":"Tolerance induction by the blockade of CD40\/CD154 interaction in pemphigus vulgaris mouse model","volume":"126","author":"Aoki-Ota","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2011.10.002_bb0110","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1046\/j.1523-1747.2003.12090.x","article-title":"Suppression of the immune response against exogenous desmoglein 3 in desmoglein 3 knockout mice: an implication for gene therapy","volume":"120","author":"Ohyama","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2011.10.002_bb0115","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1038\/sj.jid.5700970","article-title":"Human bullous pemphigoid antigen 2 transgenic skin elicits specific IgG in wild-type mice","volume":"127","author":"Olasz","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2011.10.002_bb0120","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1172\/JCI8748","article-title":"Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus","volume":"105","author":"Amagai","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2011.10.002_bb0125","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI200521386","article-title":"Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen","volume":"115","author":"Sitaru","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2011.10.002_bb0130","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/jid.2008.364","article-title":"Transient anti-CD40L co-stimulation blockade prevents immune responses against human bullous pemphigoid antigen 2: implications for gene therapy","volume":"129","author":"Lanschuetzer","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2011.10.002_bb0195","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1172\/JCI5388","article-title":"Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis","volume":"103","author":"Howard","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2011.10.002_bb0140","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.4049\/jimmunol.160.5.2158","article-title":"Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function","volume":"160","author":"Kalled","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2011.10.002_bb0145","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/art.11230","article-title":"Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis","volume":"48","author":"Quezada","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2011.10.002_bb0150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.0022-202X.2003.22126.x","article-title":"Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients","volume":"122","author":"Di Zenzo","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2011.10.002_bb0155","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.clim.2008.04.012","article-title":"Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid","volume":"128","author":"Di Zenzo","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2011.10.002_bb0200","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/jid.2011.180","article-title":"Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study","volume":"131","author":"Di Zenzo","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2011.10.002_bb0165","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/jid.2009.309","article-title":"Sequential intramolecular epitope spreading of humoral responses to human BPAG2 in a transgenic model","volume":"130","author":"Di Zenzo","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2011.10.002_bb0170","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.4049\/jimmunol.1000667","article-title":"Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model","volume":"185","author":"Li","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2011.10.002_bb0175","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1172\/JCI117826","article-title":"The role of complement in experimental bullous pemphigoid","volume":"95","author":"Liu","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2011.10.002_bb0180","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2353\/ajpath.2010.090744","article-title":"Blockade of autoantibody-initiated tissue damage by using recombinant fab antibody fragments against pathogenic autoantigen","volume":"176","author":"Wang","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.clim.2011.10.002_bb0185","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/jid.2008.305","article-title":"IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment","volume":"129","author":"Iwata","year":"2009","journal-title":"J. Invest. Dermatol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661611003019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661611003019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:56:32Z","timestamp":1761494192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661611003019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1521661611003019"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2011.10.002","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2011.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}